HEADER SUGAR BINDING PROTEIN 26-JUN-12 4FQZ TITLE CRYSTAL STRUCTURE OF A PROTEASE-RESISTANT MUTANT FORM OF HUMAN TITLE 2 GALECTIN-8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN, C-TERMINAL COMPND 5 CARBOHYDRATE RECOGNITION DOMAIN; COMPND 6 SYNONYM: GAL-8, PO66 CARBOHYDRATE-BINDING PROTEIN, PO66-CBP, PROSTATE COMPND 7 CARCINOMA TUMOR ANTIGEN 1, PCTA-1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS8; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS CARBOHYDRATE/SUGAR BINDING, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.YOSHIDA,S.KAMITORI REVDAT 5 29-JUL-20 4FQZ 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 16-AUG-17 4FQZ 1 SOURCE REMARK REVDAT 3 03-JUL-13 4FQZ 1 JRNL REVDAT 2 12-SEP-12 4FQZ 1 JRNL REVDAT 1 11-JUL-12 4FQZ 0 SPRSDE 11-JUL-12 4FQZ 3NAJ JRNL AUTH H.YOSHIDA,S.YAMASHITA,M.TERAOKA,A.ITOH,S.NAKAKITA,N.NISHI, JRNL AUTH 2 S.KAMITORI JRNL TITL X-RAY STRUCTURE OF A PROTEASE-RESISTANT MUTANT FORM OF HUMAN JRNL TITL 2 GALECTIN-8 WITH TWO CARBOHYDRATE RECOGNITION DOMAINS JRNL REF FEBS J. V. 279 3937 2012 JRNL REFN ISSN 1742-464X JRNL PMID 22913484 JRNL DOI 10.1111/J.1742-4658.2012.08753.X REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 44256.570 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 9630 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1001 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1248 REMARK 3 BIN R VALUE (WORKING SET) : 0.3130 REMARK 3 BIN FREE R VALUE : 0.3890 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2332 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 43 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.47000 REMARK 3 B22 (A**2) : 14.47000 REMARK 3 B33 (A**2) : -28.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.45 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.59 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 26.13 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FQZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000073245. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10378 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.38500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2YV8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 20000, 0.1M BICINE, 2% REMARK 280 DIOXANE, PH 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.91000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 39.62950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 39.62950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 97.36500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 39.62950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 39.62950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.45500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 39.62950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 39.62950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 97.36500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 39.62950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 39.62950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.45500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 64.91000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHOR STATES THAT THE BIOLOGICAL ASSEMBLY IS MONOMER OR REMARK 300 UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 7 59.59 -148.75 REMARK 500 LYS A 222 -74.40 -58.42 REMARK 500 SER A 223 17.98 -61.25 REMARK 500 SER A 258 127.40 -179.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VKL RELATED DB: PDB REMARK 900 THE SAME PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8 IN REMARK 900 COMPLEX WITH TWO LACTOSE MOLECULES REMARK 900 RELATED ID: 3VKM RELATED DB: PDB REMARK 900 THE SAME PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8 IN REMARK 900 COMPLEX WITH SIALYLLACTOSE AND LACTOSE DBREF 4FQZ A 1 155 UNP O00214 LEG8_HUMAN 1 155 DBREF 4FQZ A 184 317 UNP O00214 LEG8_HUMAN 184 317 SEQADV 4FQZ HIS A 156 UNP O00214 LINKER SEQADV 4FQZ MET A 157 UNP O00214 LINKER SEQRES 1 A 291 MET MET LEU SER LEU ASN ASN LEU GLN ASN ILE ILE TYR SEQRES 2 A 291 ASN PRO VAL ILE PRO PHE VAL GLY THR ILE PRO ASP GLN SEQRES 3 A 291 LEU ASP PRO GLY THR LEU ILE VAL ILE ARG GLY HIS VAL SEQRES 4 A 291 PRO SER ASP ALA ASP ARG PHE GLN VAL ASP LEU GLN ASN SEQRES 5 A 291 GLY SER SER MET LYS PRO ARG ALA ASP VAL ALA PHE HIS SEQRES 6 A 291 PHE ASN PRO ARG PHE LYS ARG ALA GLY CYS ILE VAL CYS SEQRES 7 A 291 ASN THR LEU ILE ASN GLU LYS TRP GLY ARG GLU GLU ILE SEQRES 8 A 291 THR TYR ASP THR PRO PHE LYS ARG GLU LYS SER PHE GLU SEQRES 9 A 291 ILE VAL ILE MET VAL LEU LYS ASP LYS PHE GLN VAL ALA SEQRES 10 A 291 VAL ASN GLY LYS HIS THR LEU LEU TYR GLY HIS ARG ILE SEQRES 11 A 291 GLY PRO GLU LYS ILE ASP THR LEU GLY ILE TYR GLY LYS SEQRES 12 A 291 VAL ASN ILE HIS SER ILE GLY PHE SER PHE SER SER HIS SEQRES 13 A 291 MET ARG LEU PRO PHE ALA ALA ARG LEU ASN THR PRO MET SEQRES 14 A 291 GLY PRO GLY ARG THR VAL VAL VAL LYS GLY GLU VAL ASN SEQRES 15 A 291 ALA ASN ALA LYS SER PHE ASN VAL ASP LEU LEU ALA GLY SEQRES 16 A 291 LYS SER LYS ASP ILE ALA LEU HIS LEU ASN PRO ARG LEU SEQRES 17 A 291 ASN ILE LYS ALA PHE VAL ARG ASN SER PHE LEU GLN GLU SEQRES 18 A 291 SER TRP GLY GLU GLU GLU ARG ASN ILE THR SER PHE PRO SEQRES 19 A 291 PHE SER PRO GLY MET TYR PHE GLU MET ILE ILE TYR CYS SEQRES 20 A 291 ASP VAL ARG GLU PHE LYS VAL ALA VAL ASN GLY VAL HIS SEQRES 21 A 291 SER LEU GLU TYR LYS HIS ARG PHE LYS GLU LEU SER SER SEQRES 22 A 291 ILE ASP THR LEU GLU ILE ASN GLY ASP ILE HIS LEU LEU SEQRES 23 A 291 GLU VAL ARG SER TRP HET BGC B 1 12 HET GAL B 2 11 HET EDO A 403 4 HET EDO A 404 4 HET EDO A 405 4 HET EDO A 406 4 HET EDO A 407 4 HET EDO A 408 4 HET EDO A 409 4 HET EDO A 410 4 HET EDO A 411 4 HET EDO A 412 4 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 BGC C6 H12 O6 FORMUL 2 GAL C6 H12 O6 FORMUL 3 EDO 10(C2 H6 O2) FORMUL 13 HOH *43(H2 O) HELIX 1 1 GLY A 131 ILE A 135 5 5 HELIX 2 2 PHE A 153 ARG A 184 5 6 HELIX 3 3 GLU A 296 ILE A 300 5 5 SHEET 1 A 6 LEU A 5 ASN A 6 0 SHEET 2 A 6 PHE A 187 LEU A 191 -1 O ARG A 190 N ASN A 6 SHEET 3 A 6 THR A 302 GLY A 307 -1 O LEU A 303 N ALA A 189 SHEET 4 A 6 PHE A 214 ALA A 220 -1 N ASN A 215 O ASN A 306 SHEET 5 A 6 ASP A 225 ARG A 233 -1 O LEU A 230 N VAL A 216 SHEET 6 A 6 ALA A 238 PHE A 244 -1 O ALA A 238 N ARG A 233 SHEET 1 B 6 ILE A 11 TYR A 13 0 SHEET 2 B 6 ASN A 145 SER A 152 -1 O ILE A 149 N ILE A 12 SHEET 3 B 6 LEU A 32 HIS A 38 -1 N ARG A 36 O SER A 148 SHEET 4 B 6 SER A 102 VAL A 109 -1 O ILE A 105 N ILE A 35 SHEET 5 B 6 LYS A 113 VAL A 118 -1 O GLN A 115 N MET A 108 SHEET 6 B 6 LYS A 121 GLY A 127 -1 O THR A 123 N VAL A 116 SHEET 1 C 6 PHE A 19 THR A 22 0 SHEET 2 C 6 THR A 137 GLY A 142 -1 O LEU A 138 N GLY A 21 SHEET 3 C 6 PHE A 46 GLN A 51 -1 N ASP A 49 O GLY A 139 SHEET 4 C 6 VAL A 62 ARG A 69 -1 O PHE A 66 N VAL A 48 SHEET 5 C 6 CYS A 75 ILE A 82 -1 O VAL A 77 N ASN A 67 SHEET 6 C 6 LYS A 85 TRP A 86 -1 O LYS A 85 N ILE A 82 SHEET 1 D 6 PHE A 19 THR A 22 0 SHEET 2 D 6 THR A 137 GLY A 142 -1 O LEU A 138 N GLY A 21 SHEET 3 D 6 PHE A 46 GLN A 51 -1 N ASP A 49 O GLY A 139 SHEET 4 D 6 VAL A 62 ARG A 69 -1 O PHE A 66 N VAL A 48 SHEET 5 D 6 CYS A 75 ILE A 82 -1 O VAL A 77 N ASN A 67 SHEET 6 D 6 GLU A 90 TYR A 93 -1 O GLU A 90 N CYS A 78 SHEET 1 E 5 VAL A 285 LYS A 291 0 SHEET 2 E 5 GLU A 277 VAL A 282 -1 N VAL A 280 O SER A 287 SHEET 3 E 5 TYR A 266 CYS A 273 -1 N TYR A 272 O LYS A 279 SHEET 4 E 5 THR A 200 VAL A 207 -1 N VAL A 201 O ILE A 271 SHEET 5 E 5 ILE A 309 ARG A 315 -1 O GLU A 313 N LYS A 204 LINK O4 BGC B 1 C1 GAL B 2 1555 1555 1.39 CISPEP 1 ILE A 17 PRO A 18 0 0.16 CISPEP 2 LYS A 57 PRO A 58 0 -0.13 CISPEP 3 LEU A 185 PRO A 186 0 -0.07 CRYST1 79.259 79.259 129.820 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012617 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012617 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007703 0.00000 MASTER 265 0 12 3 29 0 0 6 0 0 0 23 END